Machado Patrick
Related Filers (16)
- MEDIVATION, INC. (59)
- Urovant Sciences Ltd. (13)
- Adverum Biotechnologies, Inc. (12)
- CHIMERIX INC (11)
- Axovant Gene Therapies Ltd. (11)
- SCYNEXIS INC (8)
- Myovant Sciences Ltd. (8)
- Arbutus Biopharma Corp (8)
- Turning Point Therapeutics, Inc. (5)
- Arcus Biosciences, Inc. (5)
- ENDOCYTE INC (4)
- Principia Biopharma Inc. (4)
- Xenon Pharmaceuticals Inc. (4)
- INOTEK PHARMACEUTICALS CORP (3)
- ACELYRIN, Inc. (3)
- Roivant Sciences Ltd. (1)
- Show More ...
Ownership (159)
4
Thursday, 5/11/2023
ACELYRIN, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 5/4/2023
ACELYRIN, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 5/4/2023
ACELYRIN, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 8/17/2022
Turning Point Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/29/2022
Xenon Pharmaceuticals Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/24/2022
CHIMERIX INC: Statement of changes in beneficial ownership of securities
4
Thursday, 6/16/2022
Arcus Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/14/2022
Adverum Biotechnologies, Inc.: Statement of changes in beneficial ownership of securities
3
Friday, 10/1/2021
Roivant Sciences Ltd.: Initial statement of beneficial ownership of securities
4
Friday, 6/25/2021
CHIMERIX INC: Statement of changes in beneficial ownership of securities
4
Monday, 6/7/2021
Arcus Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/4/2021
Turning Point Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/3/2021
Xenon Pharmaceuticals Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 5/14/2021
Adverum Biotechnologies, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 3/24/2021
Adverum Biotechnologies, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/19/2021
Adverum Biotechnologies, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 11/5/2020
Xenon Pharmaceuticals Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 11/5/2020
Xenon Pharmaceuticals Inc.: Initial statement of beneficial ownership of securities
4
Monday, 9/28/2020
Principia Biopharma Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/25/2020
Adverum Biotechnologies, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/17/2020
Turning Point Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 6/15/2020
CHIMERIX INC: Statement of changes in beneficial ownership of securities
4
Monday, 6/8/2020
Principia Biopharma Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 6/8/2020
Arcus Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 1/3/2020
Adverum Biotechnologies, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 12/12/2019
Arcus Biosciences, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 12/12/2019
Arcus Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 8/2/2019
Adverum Biotechnologies, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Wednesday, 7/17/2019
Myovant Sciences Ltd.: Major Shareholders
SC 13D/A
Wednesday, 7/17/2019
Urovant Sciences Ltd.: Major Shareholders
SC 13D/A
Wednesday, 7/17/2019
Arbutus Biopharma Corp: Major Shareholders
SC 13D/A
Tuesday, 7/16/2019
Axovant Gene Therapies Ltd.: Major Shareholders
4
Monday, 7/15/2019
Myovant Sciences Ltd.: Statement of changes in beneficial ownership of securities
4
Monday, 7/15/2019
Axovant Gene Therapies Ltd.: Statement of changes in beneficial ownership of securities
4
Monday, 7/15/2019
Urovant Sciences Ltd.: Statement of changes in beneficial ownership of securities
4
Monday, 7/15/2019
Arbutus Biopharma Corp: Statement of changes in beneficial ownership of securities
4
Monday, 6/24/2019
CHIMERIX INC: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/19/2019
Urovant Sciences Ltd.: Statement of changes in beneficial ownership of securities
4
Friday, 6/14/2019
Urovant Sciences Ltd.: Statement of changes in beneficial ownership of securities
SC 13D
Friday, 6/14/2019
Myovant Sciences Ltd.: Major Shareholders
4
Tuesday, 6/11/2019
Principia Biopharma Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 6/11/2019
Principia Biopharma Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 6/11/2019
Urovant Sciences Ltd.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/6/2019
Urovant Sciences Ltd.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/6/2019
Myovant Sciences Ltd.: Statement of changes in beneficial ownership of securities
4
Monday, 6/3/2019
Urovant Sciences Ltd.: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/29/2019
Urovant Sciences Ltd.: Statement of changes in beneficial ownership of securities
4
Thursday, 5/23/2019
Urovant Sciences Ltd.: Statement of changes in beneficial ownership of securities
4
Monday, 5/20/2019
Urovant Sciences Ltd.: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/14/2019
Turning Point Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 5/14/2019
Turning Point Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 3/19/2019
Axovant Sciences Ltd.: Statement of changes in beneficial ownership of securities
SC 13D/A
Tuesday, 3/19/2019
Axovant Sciences Ltd.: Major Shareholders
SC 13G/A
Wednesday, 2/13/2019
Myovant Sciences Ltd.: Major Shareholders
4
Friday, 1/4/2019
SCYNEXIS INC: Statement of changes in beneficial ownership of securities
4
Friday, 12/21/2018
ENDOCYTE INC: Statement of changes in beneficial ownership of securities
SC 13D/A
Thursday, 12/20/2018
Axovant Sciences Ltd.: Major Shareholders
4
Thursday, 12/20/2018
Axovant Sciences Ltd.: Statement of changes in beneficial ownership of securities
SC 13D
Wednesday, 10/10/2018
Urovant Sciences Ltd.: Major Shareholders
4
Wednesday, 10/3/2018
Urovant Sciences Ltd.: Statement of changes in beneficial ownership of securities
3
Wednesday, 9/26/2018
Urovant Sciences Ltd.: Initial statement of beneficial ownership of securities
4
Thursday, 6/21/2018
CHIMERIX INC: Statement of changes in beneficial ownership of securities
4
Friday, 6/15/2018
Adverum Biotechnologies, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/7/2018
Axovant Sciences Ltd.: Statement of changes in beneficial ownership of securities
SC 13D/A
Thursday, 6/7/2018
Axovant Sciences Ltd.: Major Shareholders
4
Friday, 5/4/2018
ENDOCYTE INC: Statement of changes in beneficial ownership of securities
4
Wednesday, 4/4/2018
Myovant Sciences Ltd.: Statement of changes in beneficial ownership of securities
3
Thursday, 3/1/2018
ENDOCYTE INC: Initial statement of beneficial ownership of securities
4
Thursday, 3/1/2018
ENDOCYTE INC: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/20/2018
Adverum Biotechnologies, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Tuesday, 1/16/2018
Arbutus Biopharma Corp: Major Shareholders
4
Tuesday, 1/16/2018
Arbutus Biopharma Corp: Statement of changes in beneficial ownership of securities
4
Thursday, 1/4/2018
SCYNEXIS INC: Statement of changes in beneficial ownership of securities
4
Tuesday, 10/17/2017
Arbutus Biopharma Corp: Statement of changes in beneficial ownership of securities
SC 13D/A
Tuesday, 10/17/2017
Arbutus Biopharma Corp: Major Shareholders
4
Wednesday, 7/19/2017
Axovant Sciences Ltd.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/29/2017
CHIMERIX INC: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/21/2017
INOTEK PHARMACEUTICALS CORP: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/14/2017
Adverum Biotechnologies, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 3/16/2017
Adverum Biotechnologies, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 3/16/2017
Adverum Biotechnologies, Inc.: Initial statement of beneficial ownership of securities
SC 13G
Friday, 2/10/2017
Myovant Sciences Ltd.: Major Shareholders
4
Thursday, 1/5/2017
SCYNEXIS INC: Statement of changes in beneficial ownership of securities
3
Wednesday, 10/26/2016
Myovant Sciences Ltd.: Initial statement of beneficial ownership of securities
3
Wednesday, 10/19/2016
Axovant Sciences Ltd.: Initial statement of beneficial ownership of securities
3
Wednesday, 10/19/2016
Arbutus Biopharma Corp: Initial statement of beneficial ownership of securities
SC 13D
Wednesday, 10/19/2016
Arbutus Biopharma Corp: Major Shareholders
SC 13D
Wednesday, 10/19/2016
Axovant Sciences Ltd.: Major Shareholders
4
Friday, 9/30/2016
MEDIVATION, INC.: Statement of changes in beneficial ownership of securities
4
Friday, 9/16/2016
SCYNEXIS INC: Statement of changes in beneficial ownership of securities
4
Thursday, 8/18/2016
INOTEK PHARMACEUTICALS CORP: Statement of changes in beneficial ownership of securities
3
Thursday, 8/18/2016
INOTEK PHARMACEUTICALS CORP: Initial statement of beneficial ownership of securities
4
Tuesday, 6/28/2016
SCYNEXIS INC: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/28/2016
CHIMERIX INC: Statement of changes in beneficial ownership of securities
4
Thursday, 6/23/2016
MEDIVATION, INC.: Statement of changes in beneficial ownership of securities
4
Monday, 6/6/2016
SCYNEXIS INC: Statement of changes in beneficial ownership of securities
4
Thursday, 1/21/2016
MEDIVATION, INC.: Statement of changes in beneficial ownership of securities
4
Wednesday, 12/30/2015
CHIMERIX INC: Statement of changes in beneficial ownership of securities
4
Monday, 9/28/2015
MEDIVATION, INC.: Statement of changes in beneficial ownership of securities
3
Monday, 9/28/2015
SCYNEXIS INC: Initial statement of beneficial ownership of securities